A randomized controlled trial (RCT) evaluated whether vaporized nicotine products (VNPs) are more effective than nicotine replacement therapies (NRT) for smoking cessation among people experiencing social disadvantage. 

Obesity and type 2 diabetes in adolescence can interfere with bone development, potentially increasing the risk of fractures and osteoporosis later in life, according to a study being presented Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

Researchers from The University of Texas at Austin created a new non-invasive, wearable sensor designed to measure a user's hydration levels continuously, in real time

Do infectious disease outbreaks breed political mistrust? Ore Koren, Indiana University Bloomington (USA), and Nils Weidmann, University of Konstanz (Germany), have found out that they do. Their study will soon be published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to a new study being presented Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

A new laboratory study shows that a single serving of the popular sweetener erythritol impacts cells in ways that could constrict blood vessels and impair the body's ability to bust up clots. 

UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT and genomics company Illumina Ventures are using optogenetics — the use of light to probe the functions of living tissue — to find compounds to help our bodies more effectively help themselves in times of physiological stress. Using an optogenetic platform developed in synthetic biologist Max Wilson’s lab at UCSB, they have already discovered dozens of molecules that can act as pan-antivirals and, specifically, two chemical scaffolds that could serve as promising development candidates in the host-directed antiviral space.